23655-60-9Relevant articles and documents
TLR7 AGONISTS
-
, (2021/05/28)
The present invention relates to TLR7 agonists according to Formula I and their use in the treatment of diseases such as cancer and infectious disease.
The present invention relates to TLR7 agonists according to Formula I and their use in the treatment of diseases such as cancer and infectious disease.